Prognosis of lung cancer patients followed in the intensive care unit : A cross-sectional study
Introduction: Lung cancer is the most common solid organ malignancy requiring intensive care unit (ICU) admission. For many years, lung cancer patients were not considered in the priority patient category for admission to ICU because of their high mortality rate and poor response to therapy. Considering the developments in treatment modalities, we aimed to reevaluate the prognosis of patients with lung cancer in the ICU.
Materials and Methods: Patients characteristics, date of diagnosis, the reason for ICU admission, the stage of cancer, histopathological type, history of chemotherapy, radiotherapy, or surgery for cancer, and APACHE-II and Charlson comorbidity index (CCI) were recorded retrospectively.
Result: A total of 100 patients had a mean age of 69.7 ± 9.0 years. Among these patients, 18% had small cell lung cancer, while 82% had non-small cell lung cancer. The in-hospital mortality rate was 69% for all patients, while among those discharged from the ICU, the first 6-month mortality rate was 58.1%. The median survival time was 8.2 months. Advanced age, the need for mechanical ventilation, the need for vasopressors, a high APACHE -II, and the CCI all reduced survival in multivariate analysis, whereas chemotherapy and surgical history improved survival.
Conclusions: Patients admitted to the ICU with lung cancer continue to experience a high mortality rate. However, identifying the factors that are associated with survival can be crucial in establishing care plans and prioritizing ICU admission for further therapy.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:71 |
|---|---|
| Enthalten in: |
Tuberkuloz ve toraks - 71(2023), 2 vom: 01. Juni, Seite 138-147 |
| Sprache: |
Türkisch |
|---|
| Weiterer Titel: |
Yoğun bakım ünitesinde izlenen akciğer kanseri hastalarının prognozu: Kesitsel çalışma |
|---|
| Beteiligte Personen: |
Özpınar, Şeyda Nur [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 23.06.2023 Date Revised 01.03.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.5578/tt.20239917 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358468361 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358468361 | ||
| 003 | DE-627 | ||
| 005 | 20240301231951.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||tur c | ||
| 024 | 7 | |a 10.5578/tt.20239917 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1313.xml |
| 035 | |a (DE-627)NLM358468361 | ||
| 035 | |a (NLM)37345396 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a tur | ||
| 100 | 1 | |a Özpınar, Şeyda Nur |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prognosis of lung cancer patients followed in the intensive care unit |b A cross-sectional study |
| 246 | 3 | 3 | |a Yoğun bakım ünitesinde izlenen akciğer kanseri hastalarının prognozu: Kesitsel çalışma |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.06.2023 | ||
| 500 | |a Date Revised 01.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Introduction: Lung cancer is the most common solid organ malignancy requiring intensive care unit (ICU) admission. For many years, lung cancer patients were not considered in the priority patient category for admission to ICU because of their high mortality rate and poor response to therapy. Considering the developments in treatment modalities, we aimed to reevaluate the prognosis of patients with lung cancer in the ICU | ||
| 520 | |a Materials and Methods: Patients characteristics, date of diagnosis, the reason for ICU admission, the stage of cancer, histopathological type, history of chemotherapy, radiotherapy, or surgery for cancer, and APACHE-II and Charlson comorbidity index (CCI) were recorded retrospectively | ||
| 520 | |a Result: A total of 100 patients had a mean age of 69.7 ± 9.0 years. Among these patients, 18% had small cell lung cancer, while 82% had non-small cell lung cancer. The in-hospital mortality rate was 69% for all patients, while among those discharged from the ICU, the first 6-month mortality rate was 58.1%. The median survival time was 8.2 months. Advanced age, the need for mechanical ventilation, the need for vasopressors, a high APACHE -II, and the CCI all reduced survival in multivariate analysis, whereas chemotherapy and surgical history improved survival | ||
| 520 | |a Conclusions: Patients admitted to the ICU with lung cancer continue to experience a high mortality rate. However, identifying the factors that are associated with survival can be crucial in establishing care plans and prioritizing ICU admission for further therapy | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Gürün Kaya, Aslıhan |e verfasserin |4 aut | |
| 700 | 1 | |a Öz, Miraç |e verfasserin |4 aut | |
| 700 | 1 | |a Erol, Serhat |e verfasserin |4 aut | |
| 700 | 1 | |a Arslan, Fatma |e verfasserin |4 aut | |
| 700 | 1 | |a Çiledağ, Aydın |e verfasserin |4 aut | |
| 700 | 1 | |a Kaya, Akın |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Tuberkuloz ve toraks |d 2003 |g 71(2023), 2 vom: 01. Juni, Seite 138-147 |w (DE-627)NLM147934990 |x 2980-3187 |7 nnns |
| 773 | 1 | 8 | |g volume:71 |g year:2023 |g number:2 |g day:01 |g month:06 |g pages:138-147 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5578/tt.20239917 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 71 |j 2023 |e 2 |b 01 |c 06 |h 138-147 | ||